Piero Parchi
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (11)
Year:
2023
Year:
2023
Year:
2023
Background Intravascular large B‐cell lymphoma (IVLBCL) is a rare extranodal lymphoma that is characterized by the selective growth of neoplastic cells in blood vessels, representing a potentially treatable cause of rapidly progressive dementia (RPD). Given its diverse clinical and instrumental presentation, it is often misdiagnosed with more common RPD causes, for example, Creutzfeldt‐Jakob disease (CJD) or vascular dementia. Methods This study presents the clinical and histopathological characteristics of four IVLBCL cases that we diagnosed post‐mortem over 20 years among over 600 brain samples received as suspected CJD cases at our prion disease reference center. Results Our patients exhibited various presenting symptoms, including behavioral disturbances, disorientation, and alertness fluctuations. The diagnostic tests performed at the time, including blood work, cerebrospinal fluid (CSF) analyses, electroencephalography, and neuroimaging, yielded nonspecific and occasionally misleading results. Consequently, the patients were repeatedly diagnosed as variably having CJD, epilepsy, vascular dementia, and encephalitis. The stored CSF samples of two patients tested negative at prion real‐time quaking‐induced conversion (RT‐QuIC), which we performed afterwards for research purposes. Neuropathological analysis revealed a differential involvement of various brain areas, with frontotemporal neocortices being the most affected. Conclusions Our results confirm the significant clinical and instrumental heterogeneity of IVLBCL. Neuropathological evidence of the preferential involvement of frontotemporal neocortices, potentially conditioning the clinical phenotype, could be relevant to reach an early diagnosis. Finally, given the therapeutic implications of its misdiagnosis with CJD, we emphasize the utility of prion RT‐QuIC as a test for ruling out CJD in these patients.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (16)
Per Selnes
University of Oslo
Eloy Rodriguez-Rodríguez
Instituto de Investigación Marqués de Valdecilla
Rocco Liguori
Full Professor of Neurology
University of Bologna
Alisha Daniels
MD, MHA; Executive Research Director/Assistant Professor
Washington University in St. Louis
Sabine Hellwig
Senior physican/ APL Professor
University Medical Center Freiburg
Karen Rodrigue
Associate Professor
University of Texas at Dallas
Dina Silva
Assistant Professor of Cognitive Neuroscience and Neuropsychology
Universidade do Algarve
sabina capellari
Associate Professor
University of Bologna
Oskar Hansson
Full professor of Neurology
Lund University
Anna ladogana
Head of research
Istituto Superiore di Sanità
Andrea Mastrangelo
University of Bologna
Yvonne Freund-Levi
Karolinska Institutet
Samir Abu-Rumeileh
Martin Luther University Halle-Wittenberg
Sofia Dellavalle
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Rik Ossenkoppele
Associate Professor in Translational Neurosience
VU Amsterdam
Patrick Oeckl
-
Make your next move.
Prepare your application
Review drafts before you send them.